Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Integra LifeSciences Holdings Corporation - Common Stock (NQ: IART )

22.39 +0.12 (+0.56%)
Streaming Delayed Price Updated: 11:47 AM EDT, Mar 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Integra LifeSciences Holdings Corporation - Common Stock

< Previous 1 2 3 4 Next >
3 Reasons IART is Risky and 1 Stock to Buy Instead
While the broader market has struggled with the S&P 500 down 1.3% since September 2024, Integra LifeSciences has surged ahead as its stock price has climbed by 31.6% to $22.79 per share. This... 
Via StockStory
Topics Stocks
Exposures US Equities
3 Small-Cap Stocks in the Doghouse
Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and their stock prices) often stay small... 
Via StockStory
Teleflex Earnings: What To Look For From TFX
Medical technology company Teleflex (NYSE:TFX) will be reporting earnings tomorrow before market open. Here’s what to look for. 
Via StockStory
What To Expect From LeMaitre’s (LMAT) Q4 Earnings
Medical device company LeMaitre Vascular (NASDAQ:LMAT) will be announcing earnings results tomorrow after the bell. Here’s what to expect. 
Via StockStory
Earnings Scheduled For February 25, 2025
Via Benzinga
Unveiling 10 Analyst Insights On Integra Lifesciences
Via Benzinga
Expert Outlook: Integra Lifesciences Through The Eyes Of 8 Analysts
Via Benzinga
Integra LifeSciences Analysts Cut Their Forecasts After Q2 Results
Via Benzinga
Why Is Integra LifeSciences (IART) Stock Rocketing Higher Today
Shares of medical device company Integra LifeSciences (NASDAQ:IART) jumped 13.6% in the afternoon session after the company reported strong fourth quarter 2024 results that beat analysts' EPS and... 
Via StockStory
Integra LifeSciences (NASDAQ:IART) Misses Q4 Revenue Estimates
Medical device company Integra LifeSciences (NASDAQ:IART) missed Wall Street’s revenue expectations in Q4 CY2024, but sales rose 11.5% year on year to $442.6 million. Next quarter’s revenue guidance of... 
Via StockStory
Integra LifeSciences (IART) Reports Earnings Tomorrow: What To Expect
Medical device company Integra LifeSciences (NASDAQ:IART) will be announcing earnings results tomorrow before market hours. Here’s what to look for. 
Via StockStory
Meet the Only 3 S&P 500 Stocks That Are Beating Nvidia This Year
Via The Motley Fool
Topics Stocks
Exposures US Equities
NASDAQ:IART is an undervalued gem with solid fundamentals.
INTEGRA LIFESCIENCES HOLDING (NASDAQ:IART) is an undervalued gem with solid fundamentals. 
Via Chartmill
8 Analysts Have This To Say About Integra Lifesciences
Via Benzinga
A Glimpse Into The Expert Outlook On Integra Lifesciences Through 8 Analysts
Via Benzinga
Why Is Integra LifeSciences Stock Soaring On Monday?
Integra LifeSciences' Q3 results show adjusted EPS of $0.41 and revenue at $380.83 million. Codman segment grows 1%, while Tissue Tech sees a 3.6% decline. 
Via Benzinga
Integra LifeSciences Posts Upbeat Results, Joins Air Transport Services, Freshpet, Yum China And Other Big Stocks Moving Higher On Monday
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Wall Street's Top 10 Stock Calls This Week - Saturday, Aug. 3
What has Wall Street been buzzing about this week? Here are the top 5 buy calls and the top 5 sell calls made by Wall Street's best analysts during the trading week of July 29 through Aug. 2. 
Via Talk Markets
Why Bank of Marin Bancorp Shares Are Trading Lower? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Why Integra Lifesciences Stock Is Sinking Today
Q2 revenue and earnings beats didn't make up for the company's full-year guidance cut. 
Via The Motley Fool
Topics Earnings
Exposures Financial
IART Stock Earnings: Integra Lifesciences Beats EPS, Beats Revenue for Q2 2024
IART stock results show that Integra Lifesciences beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
Via InvestorPlace
Abbott, Integra LifeSciences And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Via Benzinga
The 3 Best Brain-Computer Interface Stocks to Buy Now
With the number of U.S. citizens aged 65 and above growing to 55.8 million, we could see brain-computer interface stocks accelerate. 
Via InvestorPlace
For those who appreciate value investing, NASDAQ:IART is a compelling option with its solid fundamentals.
INTEGRA LIFESCIENCES HOLDING (NASDAQ:IART), an undervalued stock with good fundamentals. 
Via Chartmill
NASDAQ:IART appears to be flying under the radar despite its strong fundamentals.
Despite its impressive fundamentals, INTEGRA LIFESCIENCES HOLDING (NASDAQ:IART) remains undervalued. 
Via Chartmill
CrowdStrike, KKR, GoDaddy To Join S&P 500 In Quarterly Rebalance; Stocks Jump
KKR and GoDaddy also will join before the open on June 24. 
Via Investor's Business Daily
Topics Stocks
Exposures US Equities
$1.5M Bet On This Healthcare Stock? Check Out These 4 Stocks Insiders Are Buying
Via Benzinga
NASDAQ:IART is a prime example of a stock that offers more than what meets the eye in terms of fundamentals.
Investors should take notice ofINTEGRA LIFESCIENCES HOLDING (NASDAQ:IART)—it offers a great deal for the fundamentals it presents. 
Via Chartmill
Stocks On Track For Third Green Session, Palantir Ignites Rally In Chipmakers, Commodities Rebound: What's Driving Markets Monday?
The stock market is poised to mark a third consecutive session of gains, with major indices all trading in the green during midday trading in New York on Monday, as traders continue to react positively... 
Via Benzinga
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.